Article
Stathmin expression associates with vascular and immune responses in aggressive breast cancer subgroups.
Scientific reports - 19 Feb 2020
Askeland Cecilie, Wik Elisabeth, Finne Kenneth, Birkeland Even, Arnes Jarle B, Collett Karin, Knutsvik Gøril, Krüger Kristi, Davidsen Benedicte, Aas Turid, Eide Geir Egil, Stefansson Ingunn M, Foulkes William D, Akslen Lars A
Abstract excerpt
Studies indicate that stathmin expression associates with PI3K activation in breast cancer, suggesting stathmin as a marker for targetable patient subgroups. Here we assessed stathmin in relation to tumour proliferation, vascular and immune responses, BRCA1 germline status, basal-like differentiation, clinico-pathologic features, and survival. Immunohistochemical staining was performed on breast cancers from two...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.